HIV Alert: Managing HIV/HCV Coinfection

In this downloadable slideset, Annie Luetkemeyer, MD, and Mark Sulkowski, MD, provide expert insight on managing HIV in the setting of HCV coinfection.
Format: Microsoft PowerPoint (.ppt)
File Size: 401 KB
Released: December 5, 2017

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

Expert commentary from Dr. Annie Luetkemeyer on drug–drug interactions with direct-acting antivirals (DAAs) and antiretroviral therapy (ART)

Annie Luetkemeyer, MD Released: December 12, 2018

Downloadable slideset covering key HIV studies presented at IDWeek, Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options

Babafemi Taiwo, MBBS Released: December 5, 2018

Study 1878: Suppression maintained through Week 48 after switch to BIC/FTC/TAF with M184V/I presented at Glasgow 2018 reported by Clinical Care Options

Released: November 30, 2018

Phase III NAMSAL ANRS 12313: Week 48 results from Glasgow 2018 on DTG vs EFV 400 mg + 3TC/TDF in ART-naive adults, as reported by Clinical Care Options (CCO).

Released: November 30, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?